Global Decentralized & POC Coagulation Testing Market Research Report 2024

Publication ID:

PB502241868

Publication Date:

March 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result of the sudden rise in blood coagulation factors. In addition, patients undergoing cardiovascular surgery also present haemostatic disorders along with their existing disease state besides their adjunctive medication or the presence of any coagulation disturbances induced by a cardiopulmonary bypass surgery. POC (Point of care) coagulation testing monitors are available for monitoring preoperative coagulation especially in procedures involving cardiovascular surgeries such as cardiac bypass, angioplasty, etc.
The global Decentralized & POC Coagulation Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Decentralized & POC Coagulation Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized & POC Coagulation Testing.
Report Scope
The Decentralized & POC Coagulation Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decentralized & POC Coagulation Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized & POC Coagulation Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics
Segment by Type
Anti-Coagulated Plasma Technology
Whole Blood Specimen Testing Kits
Satellite Anticoagulation Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized & POC Coagulation Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized & POC Coagulation Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-Coagulated Plasma Technology
1.2.3 Whole Blood Specimen Testing Kits
1.2.4 Satellite Anticoagulation Therapy
1.3 Market by Application
1.3.1 Global Decentralized & POC Coagulation Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized & POC Coagulation Testing Market Perspective (2019-2030)
2.2 Decentralized & POC Coagulation Testing Growth Trends by Region
2.2.1 Global Decentralized & POC Coagulation Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Decentralized & POC Coagulation Testing Historic Market Size by Region (2019-2024)
2.2.3 Decentralized & POC Coagulation Testing Forecasted Market Size by Region (2025-2030)
2.3 Decentralized & POC Coagulation Testing Market Dynamics
2.3.1 Decentralized & POC Coagulation Testing Industry Trends
2.3.2 Decentralized & POC Coagulation Testing Market Drivers
2.3.3 Decentralized & POC Coagulation Testing Market Challenges
2.3.4 Decentralized & POC Coagulation Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized & POC Coagulation Testing Players by Revenue
3.1.1 Global Top Decentralized & POC Coagulation Testing Players by Revenue (2019-2024)
3.1.2 Global Decentralized & POC Coagulation Testing Revenue Market Share by Players (2019-2024)
3.2 Global Decentralized & POC Coagulation Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Decentralized & POC Coagulation Testing Revenue
3.4 Global Decentralized & POC Coagulation Testing Market Concentration Ratio
3.4.1 Global Decentralized & POC Coagulation Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized & POC Coagulation Testing Revenue in 2023
3.5 Decentralized & POC Coagulation Testing Key Players Head office and Area Served
3.6 Key Players Decentralized & POC Coagulation Testing Product Solution and Service
3.7 Date of Enter into Decentralized & POC Coagulation Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized & POC Coagulation Testing Breakdown Data by Type
4.1 Global Decentralized & POC Coagulation Testing Historic Market Size by Type (2019-2024)
4.2 Global Decentralized & POC Coagulation Testing Forecasted Market Size by Type (2025-2030)
5 Decentralized & POC Coagulation Testing Breakdown Data by Application
5.1 Global Decentralized & POC Coagulation Testing Historic Market Size by Application (2019-2024)
5.2 Global Decentralized & POC Coagulation Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Decentralized & POC Coagulation Testing Market Size (2019-2030)
6.2 North America Decentralized & POC Coagulation Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Decentralized & POC Coagulation Testing Market Size by Country (2019-2024)
6.4 North America Decentralized & POC Coagulation Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized & POC Coagulation Testing Market Size (2019-2030)
7.2 Europe Decentralized & POC Coagulation Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Decentralized & POC Coagulation Testing Market Size by Country (2019-2024)
7.4 Europe Decentralized & POC Coagulation Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Decentralized & POC Coagulation Testing Market Size (2019-2030)
8.2 Asia-Pacific Decentralized & POC Coagulation Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Decentralized & POC Coagulation Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Decentralized & POC Coagulation Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Decentralized & POC Coagulation Testing Market Size (2019-2030)
9.2 Latin America Decentralized & POC Coagulation Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Decentralized & POC Coagulation Testing Market Size by Country (2019-2024)
9.4 Latin America Decentralized & POC Coagulation Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized & POC Coagulation Testing Market Size (2019-2030)
10.2 Middle East & Africa Decentralized & POC Coagulation Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Decentralized & POC Coagulation Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Decentralized & POC Coagulation Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Decentralized & POC Coagulation Testing Introduction
11.1.4 Roche Diagnostics Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Decentralized & POC Coagulation Testing Introduction
11.2.4 Abbott Laboratories Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Biosite Diagnostic
11.3.1 Biosite Diagnostic Company Detail
11.3.2 Biosite Diagnostic Business Overview
11.3.3 Biosite Diagnostic Decentralized & POC Coagulation Testing Introduction
11.3.4 Biosite Diagnostic Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.3.5 Biosite Diagnostic Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Decentralized & POC Coagulation Testing Introduction
11.4.4 Medtronic Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.4.5 Medtronic Recent Development
11.5 Trinity Biotech
11.5.1 Trinity Biotech Company Detail
11.5.2 Trinity Biotech Business Overview
11.5.3 Trinity Biotech Decentralized & POC Coagulation Testing Introduction
11.5.4 Trinity Biotech Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.5.5 Trinity Biotech Recent Development
11.6 Polartechnics
11.6.1 Polartechnics Company Detail
11.6.2 Polartechnics Business Overview
11.6.3 Polartechnics Decentralized & POC Coagulation Testing Introduction
11.6.4 Polartechnics Revenue in Decentralized & POC Coagulation Testing Business (2019-2024)
11.6.5 Polartechnics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂